Pfizer to broaden RSV portfolio with deal to acquire ReViral for up to $525 million
For this year the company, located in New York City revenue will be around 105.44 billion USD. This is according to the average of the analysts' estimates. The expected revenue would be a record for the company. This is rather significant more than 2021's revenue of 81.29 billion USD.
Historical revenues and results Pfizer plus estimates 2022
The analysts expect for 2022 a net profit of 39.47 billion USD. For this year the consensus of the result per share is a profit of 6.86 USD. So the price/earnings-ratio equals 7.24.
Huge dividend Pfizer
Per share the analysts anticipate on a dividend of 1.65 USD per share. The dividend yield is then 3.32 percent. The average dividend yield of the pharmaceutical companies is a limited 1.37 percent.Most recent target prices around 53 USD
The most recent recommendations for the pharmaceutical company are from JP Morgan, Barclays and UBS .Pfizer 's market capitalization is around 276.46 billion USD. 29
On Wednesday the stock closed at 49.66 USD.Historical stock prices Pfizer
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
